WILMINGTON, DE - Enovis (NYSE: ENOV), a prominent medical technology company with a market capitalization of $2.54 billion, has announced the appointment of Davide Visentin as the new President of ...

$40,000 of ENOVIS lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Medicare DME Competitive Bidding reforms and ...

Chicago, IL – January 24, 2025 – Today, Zacks Equity Research Equity are Enovis ENOV, Omnicell OMCL and Phreesia PHR. Link: ...

Enovis (NYSE: ENOV) announced today that it appointed Davide Visentin as the new president of its International Surgical ...

Starting from healthcare resource management to efficient handling of medical records and patient data, the Medical Info Systems industry is rapidly expanding its boundaries with each passing day.

Oak Thistle LLC acquired a new position in shares of Enovis Co. (NYSE:ENOV – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission ...

Enovis (ENOV), a global medical technology company, Friday, announced that Davide Visentin will take over as President of Enovis ...

Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis™, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr. Benjamin ...

GET MORE AI-GENERATED SIGNALS: January 21, 2025, 17:54 pm ET, BY THOMAS KEE- Contributor| Editor: Thomas H. Kee Jr. ( Follow on LinkedIn) Check the time stamp on this data. Updated AI-Generated ...

Enovis has named Davide Visentin as its new president of the international surgical business, according to a Jan. 17 report from Mass Device. Mr. Visentin will succeed Benjamin Reinmann, MD, beginning ...

On Monday, Enovis Corp (ENOV) stock saw a modest uptick, ending the day at $45.35 which represents a slight increase of $0.58 or 1.30% from the prior close of $44.77. The stock opened at $44.43 and ...

Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis™, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr ...